FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
Barclays raised its price target on PRA Health Sciences (NASDAQ: PRAH) to $115.00 (from $100.00) while maintaining a Overweight rating.